Canada markets closed

Elicera Therapeutics AB (publ) (8E8.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.0628+0.0098 (+18.49%)
At close: 11:23AM CEST
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-19,501
-16,398
-19,439
-13,120
-2,823
Depreciation & amortization
11.766
11.766
11.792
11.776
11.776
Change in working capital
-2,667
1,464
10,854
-1,184
1,906
Other working capital
-22,152
-14,924
-8,571
-14,293
-964.131
Net cash provided by operating activites
-22,151
-14,923
-8,571
-14,293
-905.251
Cash flows from investing activities
Investments in property, plant and equipment
-
-1
-
-
-58.88
Net cash used for investing activites
483.153
483.17
0
-1
-8.88
Net change in cash
-1,135
-14,493
-8,571
40,828
11,531
Cash at beginning of period
41,786
43,822
52,393
11,565
33.828
Cash at end of period
40,705
29,383
43,822
52,393
11,565
Free Cash Flow
Operating Cash Flow
-22,151
-14,923
-8,571
-14,293
-905.251
Capital Expenditure
-
-1
-
-
-58.88
Free Cash Flow
-22,152
-14,924
-8,571
-14,293
-964.131